HighTower Advisors »

Amneal Pharmaceuticals shares owned by HighTower Advisors

Quarter-by-quarter ownership of Amneal Pharmaceuticals (AMRX) shares owned by HighTower Advisors from 13F filings

Historical chart of HighTower Advisors investment in Amneal Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Amneal Pharmaceuticals held by HighTower Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amneal Pharmaceuticals by HighTower Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $1.1M 89k 12.60
2024-09-30 $103k 12k 8.45
2024-06-30 $82k 13k 6.21

More positions owned by HighTower Advisors

Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Berkshire Hathaway Inc Del Cl A (BRK.A)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Alphabet Cap Stk Cl A (GOOGL)
Exxon Mobil Corporation (XOM)
Meta Platforms Cl A (META)
JPMorgan Chase & Co. (JPM)
Johnson & Johnson (JNJ)
Vanguard Index Fds Growth Etf (VUG)

View all positions for HighTower Advisors

Top funds holding Amneal Pharmaceuticals

Vanguard Group
BlackRock
Rubric Capital Management
Tpg Gp A
Citadel Advisors
Dimensional Fund Advisors
State Street Corporation
Geode Capital Management
Assenagon Asset Management
Neuberger Berman Group
Millennium Management
Nuveen
Goldman Sachs Group
Nantahala Capital Management
BlackBarn Capital Partners

View all funds holding Amneal Pharmaceuticals